DJS Antibodies
Thomas Mills is a Research Associate Scientist II at DJS Antibodies since January 2021, previously serving as a Research Assistant. Prior experience includes a Research Assistant role at Swansea University from September 2018 to July 2019, focusing on mammalian cell culture research related to toxicology and cell survival. Thomas holds a BSc (Hons) in Pharmacology from the University of Bath (2016-2020) and completed education at Berkhamsted School from 2005 to 2015.
DJS Antibodies
1 followers
DJS Antibodies is developing novel therapeutics to treat chronic inflammatory diseases. DJS does this through the discovery and development of novel therapeutic monoclonal antibodies against GPCRs. The company's breakthrough technology enables its to produce first-in-class antibody therapeutics to previously intractable disease targets.